{
    "Trade/Device Name(s)": [
        "ImmunoCAP Specific IgE",
        "ImmunoCAP Allergen w1, Common ragweed"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K163370",
    "Predicate Device Reference 510(k) Number(s)": [
        "K962274",
        "K051218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "February 27, 2017",
    "Summary Letter Received Date": "February 28, 2017",
    "Submission Date": "February 15, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen specific IgE",
        "Amb a 1 (major allergen component of Common ragweed)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Na-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250",
        "Phadia 1000",
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Automated in vitro quantitative assay",
        "Fluorescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay (EIA)",
        "Quantitative IgE detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Allergen w1, Common ragweed reagent as part of ImmunoCAP Specific IgE assay system for quantitative measurement of allergen specific IgE",
    "Indications for Use Summary": "Aid in the clinical diagnosis of IgE mediated allergic disorders by measuring allergen specific IgE in human serum or plasma, for in vitro diagnostic use in clinical laboratories",
    "fda_folder": "Immunology"
}